Exempts SGST on specified medicines used in COVID-19, up to 31st December, 2021
Notification - The Maharashtra Goods and Services Tax Act, 2017
- Kind: Notification
- Under: The Maharashtra Goods and Services Tax Act, 2017
Text of this notification
RNI No. MAHBIL /2009/37831
HERTSE ITE qSTUS
STHTUT I I R-oF
o 1o, 3k 2R9(%0)] TEAR, TS 2%, 0L /MMYTT IR, Mok %3 [ed 2, fobmer : HUF Q.00
ITHTERUT ShHTh 320
TTFerehe UehToTT
TERTE, VA HERTE it aam dHerer
(TIT Teh, Teh~ 37 3MTUT Teh-oT ATHE UfAeg Shotel friae o ST Ficatatier) frarm o 3masr.
FINANCE DEPARTMENT
Madam Cama Marg, Hutatma Rajguru Chowk, Mantralaya,
Mumbai 400 032, dated the 14th October 2021.
NOTIFICATION
Notification No. 12/2021 - State Tax (Rate)
MaHARASHTRA GooDs AND SERVICES Tax Acr, 2017.
No. GST-1021/C.R. 92(F)/ Taxation-1.—In exercise of the powers conferred by sub-section (1) of
section 11 of the Maharashtra Goods and Services Tax Act, 2017 (Mah. XLIII of 2017) (hereafter in
this notification referred to as “the said Act”), the Government of Maharashtra, on being satisfied that
it is necessary in the public interest so to do, on the recommendations of the Council, hereby exempts
the goods specified in column (3) of the Table below, falling under the tariff item, sub-heading, heading
or Chapter as specified in the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), as the case
may be, as specified in the corresponding entry in column (2) of the said Table, from so much of the
State tax leviable thereon under section 9 of the said Act, as is in excess of the amount calculated at
the rate as specified in corresponding entry in column (4) of the aforesaid Table, namely:—
Chapter, Heading,
SI. No. | Sub-heading or Tariff Description of Goods Rate
item
(1) 3) (4)
(2
1 30 Tocilizumab Nil
30 Amphotericin B Nil
3 30 Remdesivir 2.5%
(2)
AT HAR-9-320—-2
R TERTE IE TST0S STETENUT 9T =N o, AGelon 2%, 032/ MYa 2R, Teh 22%3
Chapter, Heading,
SI. No. | Sub-heading or Tariff Description of Goods Rate
W ftem ® @
(2
4 30 Heparin( anti-coagulant) 2.5%
5 30 Itolizumab 2.5%
6 30 Posaconazole 2.5%
7 30 Infliximab 2.5%
8 30 Bamlanivimab & Etesevimab 2.5%
9 30 Casirivimab & Imdevimab 2.5%
10 30 2-Deoxy-D-Glucose 2.5%
11 30 Favipiravir 2.5%
TABLE
2. This notification shall come into force from the 1st day of October, 2021 and remain in force
up to and inclusive of the 31st December 2021.
By order and in the name of the Governor of Maharashtra,
MANDAR KELKAR,
Deputy Secretary to Government.
ON BEHALF OF GOVERNMENT PRINTING, STATIONERY AND PUBLICATION, PRINTED AND PUBLISHED BY DIRECTOR,
RUPENDRA DINESH MORE, PRINTED AT GOVERNMENT CENTRAL PRESS, 21-A, NETAJI SUBHASH ROAD, CHARNI ROAD,
MUMBALI 400 004 AND PUBLISHED AT DIRECTORATE OF GOVERNMENT PRINTING, STATIONERY AND PUBLICATIONS,
21-A, NETAJI SUBHASH ROAD, CHARNI ROAD, MUMBAI 400 004. EDITOR : DIRECTOR, RUPENDRA DINESH MORE.